An Anal fistula, also known as fistula in-ano or a small tunnel which develops between the end of bowel and skin near opening of anus. Anus is the muscular opening at the end of digestive tract. Anal Fistula is caused by an infection near anus that results in collection of pus in nearby tissue. It cause symptoms such as discomfort, irritation of skin, smelly discharge, swelling, and passing pus or blood. Mostly, surgery is recommended in most cases such as Seton procedures and Fistulotomy. Non-surgical methods are also used in treating anal fistula.

Rising incidence of inflammatory bowel diseases like Crohn’s disease, ulcerative colitis has driven the target market growth. Further, launch of new products and rising demand for non-surgical methods like adipose derived stem cells therapy, and fibrin glue injection is expected to boost the target market growth over the forecast period.

The report “Anal Fistula Treatment Market, By Type (Non-Surgical and Surgical), By Application (Intersphincteric Fistula, Transsphincteric Fistula, Suprasphincteric Fistula, and Extrasphincteric Fistula), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2032”

 Key Highlights:

• In March 2022, Ossium Health Inc., announced the FDA (Food and Drug Administration) clearance for its Investigational New Drug (IND) application for “OSSM-001” a mesenchymal stem cell (MSC) product for treating Perianal Fistulizing Crohn’s Disease.

Analyst View:

The key factor driving the Anal Fistula treatment Market is rising incidence of bowel diseases and gastrointestinal infection diseases. The awareness regarding bowel diseases, new product presence of competitors and possession uplifts the target market growth. Rising advancement in technology, modernization in healthcare machineries, increasing research and development activities in healthcare sector is expected to fruitful the Anal Fistula treatment Market growth over the forecast period.